3
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Terminated
1
Sponsor Class
INDUSTRY
1
Study Type
Interventional
1
Sponsor
Cancer Type
Thoracic
1
Other solid neoplasm
1
Conditions
Neoplasms
2
Lung Neoplasms
2
Pleural Neoplasms
1
Mesothelioma
1
Lymphoma, Follicular
1
Glioma
1
Glioblastoma
1
Dementia
1
Cognitive Dysfunction
1
Brain Neoplasms
1
Astrocytoma
1
Alzheimer Disease
1
Interventions
Pemetrexed
8
pembrolizumab
6
Cisplatin
6
LMB-100
3
Carboplatin
3
Radiosurgery
2
Plicamycin
2
Dexamethasone
2
Cryotherapy
2
vandetanib
1
tremelimumab
1
tocilizumab
1
rebastinib
1
pevonedistat
1
perflutren
1
nintedanib
1
iodixanol
1
fludarabine phosphate
1
fludarabine
1
epacadostat
1
enzalutamide
1
durvalumab
1
defactinib
1
anetumab ravtansine
1
amatuximab
1
alvocidib
1
aldesleukin
1
Vinorelbine
1
Sulfur Hexafluoride
1
Radiotherapy, Intensity-Modulated
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Terminated
×
Mesothelioma
×
Drug Delivery Systems
×
Clear all
NCT00748085
2015-07-23
ICEtheMAD
CSA Medical, Inc.
Phase NA
Terminated
5 enrolled
5 charts